A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05636215 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Unresectable or Metastatic Solid Tumors

Interventions

BIOLOGICAL: IBI354

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.